login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Biasi calls time on carotid stenting


Friday, 20 Feb 2009 10:24



A standard time limit for carotid artery stenting procedures was suggested by Giorgio Biasi of the University of Milano-Bicocca, Italy, speaking at the International Congress on Endovascular Interventions XXII in Scottsdale, Arizona, USA, this month.


Biasi presented the final results of the RISC study (Registro Italiano per lo Stenting Carotideo), a study of 1,350 cases, which found that the minimally-invasive procedure has good long-term results, both in terms of neurological complications and restenosis.


The study aimed to collect data on carotid artery stenting in a "real world" setting.


The data was compiled by professionals from across disciplines concerned with preventing stroke due to carotid plaques. "The interesting point is," said Biasi, "that the major components - vascular surgeons, radiologists and cardiologists - were roughly equally represented."


Each of the study centres was free to use different techniques and devices.


Patient follow-up took place at one, six, 12 and 24 months with computed tomography or magnetic resonance imaging, always in the presence of an independent neurologist. The primary endpoints of the study were 30-day combined any stroke and death rate, restenosis at 24 months, and stroke and death rate at 24 months.


The study found a 30-day stroke and death rate of 2.4%. Biasi highlighted a peak in complication rates in patients aged between 70 and 80 years, which fell in those over 80 years of age.


A difference between experienced and inexperienced centres (those that had performed more or less than 30 procedures respectively) was observed, but this, he said, was not found to be significant (p=.09). He also showed that the data strongly supported statin administration and the use of embolic protection devices.


"The total procedure time was very important. When the time was over 60 minutes, there was a great difference from those taking less than 30 minutes," he said.


"The presence of calcified plaques is also very important [increasing the chance of stroke and death], and the least important factor is the percentage of stenosis."


The study found no statistically significant difference between open and closed cell stent designs.


Beyond 30 days, there were 23 deaths up to two years, 15 of which were from non-neurological causes. There were 13 strokes recorded in this period and a rate of new restenosis of 4.4%.




Add New Comment

Most popular


Monday, 14 Mar 2016
Although systemic thrombolysis achieves similar rates of mortality as catheter-directed intervention for the treatment of acute pulmonary embolism, it also carries “significantly increased odds of ... Systemic thrombolysis for acute pulmonary embolism increases stroke risk compared with catheter-directed intervention

Silk Road Medical receives CE mark for next-generation Enroute transcarotid neuroprotection system
Wednesday, 16 Mar 2016
Silk Road Medical has been granted CE approval for its Enroute transcarotid neuroprotection system (NPS). The company has also reported the first patients have been treated with the system. Silk Road Medical receives CE mark for next-generation Enroute transcarotid neuroprotection system

FDA proposes ban on most powdered medical gloves
Tuesday, 22 Mar 2016
The US Food and Drug Administration has announced a proposal to ban most powdered gloves in the USA. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness ... FDA proposes ban on most powdered medical gloves

Features


A research track record helps physicians assess new technology
Tuesday, 12 Apr 2016
Scott Trerotola, Stanley Baum Professor and chief, Vascular and Interventional Radiology, University of Pennsylvania Medical Center, Philadelphia, USA, delivered the Dr Charles T Dotter Lecture at ... A research track record helps physicians assess new technology

How we innovate must change dramatically
Friday, 01 Apr 2016
In order to fully capitalise on the potential of advances in materials, drugs, biologics, sensing, informatics, guidance, manufacturing processes and marketing, an organised collaborative approach to ... How we innovate must change dramatically

Profiles


Gabriel Bartal
Thursday, 26 Nov 2015
“In the early days, I used to have to cut a 7F plastic tube, make side holes, send it off for ... Gabriel Bartal

Lindsay Machan
Thursday, 28 May 2015
“Focusing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions